Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer

doi:10.3748/wjg.v23.i14.2575

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8183)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

681

WORD

308

HTML

4150

Figures (1-2)

216

Tables (1-5)

210

Sum=5565

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1010

Download

1608

Sum=2618

Apr 14, 2017 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 14, 2017; 23(14): 2575-2584
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2575

Table 1 Mean dose and duration of omeprazole administered orally and intravenously

OME	Cases	administered dose (mg)				OME administration (No. of days)
OME	Cases	Mean ± SD	95%CI	Max	Min	Mean ± SD	95%CI	Max	Min
Oral¹	7	260.0 ± 143.2	127.6-392.4	546	182	11.0 ± 8.0	3.6-18.3	28	7
IV²	47	217.2 ± 184.8	162.8-271.3	940	40	3.8 ± 3.0	2.9-4.6	16	1
IV + Oral³	9	406.2 ± 184.9	264.1-548.4	756	151	13.7 ± 7.0	8.2-19.1	28	7

¹Oral OME multiplied by 65%;

²OME received intravenously;

³Oral OME multiplied by 65% plus OME received intravenously. OME: Omeprazole.

Citation: Zhang JL, Liu M, Yang Q, Lin SY, Shan HB, Wang HY, Xu GL. Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer. World J Gastroenterol 2017; 23(14): 2575-2584
URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2575.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2575